Search Results 1041-1050 of 91062 for Metastasis

  1. A Safety and Efficacy Study of Domvanalimab + Zimberelimab Combination Therapy in Participants With Advanced Upper Gastrointestinal Tract Malignancies - Mayo Clinic

    ... metastatic gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma. Participation eligibility. Participant eligibility includes age, gender ...

  2. Cancer Clinical Trials - Medical Professionals

    ... metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety and tolerability and determine RP2D of YH001 ...

  3. Spinal cord tumor - Doctors and departments - Mayo Clinic

    ... metastasis, Glioma, Pituitary tumor, Chondrosarcoma, Glioblastoma, Bone metastasis, Chordoma, Choroidal melanoma. Show more areas of focus for Eric J. Lehrer ...

  4. Overview - Immunometabolism and Cancer Immunology Laboratory - Mayo Clinic Research

    ... metastatic ovarian cancer to patient care. ... Curtis with inquiries about research in the tumor microenvironment, immune cells and cancer metastasis in her ...

  5. Safety, Tolerability, Pharmacokinetics, And Preliminary Efficacy Of BTX-9341 In Advanced And/​or Metastatic Breast Cancer - Mayo Clinic

    Safety, Tolerability, Pharmacokinetics, And Preliminary Efficacy Of BTX-9341 In Advanced And/​or Metastatic Breast Cancer · More about research at Mayo Clinic.

  6. Doctors and departments - Mayo Clinic

    People with renal cell carcinoma who had surgery to completely remove secondary tumor growth, called metastases, had significantly improved survival ...

  7. A Study Of Single Patient Investigational Drug CPI-613 For Use In Treatment-Refractory, Metastatic Prostate Cancer - Mayo Clinic

    This is a single patient study of an investigational drug CPI-613 for treatment of metastatic prostate cancer. Participation eligibility. Participant ...

  8. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

    A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC).

  9. Spinal cord tumor - Doctors and departments - Mayo Clinic

    ... metastasis, Cervical spondylotic myelopathy, Radiculopathy, Spine deformity, Lumbar herniated disk, Spondylotic myelopathy, Thoracic herniated disk ...

  10. Pulmonary Medicine Clinical Trials - Medical Professionals

    ... Metastatic Non-small Cell Lung Cancer. Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non ...